The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Mechanisms of Sympathetic Activation in Obesity-Related Hypertension
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, cardiac norepinephrine spillover is decreased in obese normotensives and is only marginally increased in obese hypertensives59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“Most notably, elevated sympathetic activity in obesity often occurs in the absence of hypertension3,59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [61]
In the citing paper
“Sophisticated studies using microneurography and/or radiolabeled norepinephrine spillover have unequivocally supported Landsberg’s concept of sympathetic overactivity in most human obesity3,60–61,64.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [61]
In the citing paper
“First, cardiac norepinephrine spillover is decreased in obese normotensives and is only marginally increased in obese hypertensives59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [61]
In the citing paper
“Second, in obese humans renal norepinephrine spillover is not significantly higher in hypertensive than it is in normotensive subjects60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“This contrasts with marked elevation in cardiac norepinephrine spillover in lean hypertensives60.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“Most notably, elevated sympathetic activity in obesity often occurs in the absence of hypertension3,59,60–61.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
In the citing paper
“Sophisticated studies using microneurography and/or radiolabeled norepinephrine spillover have unequivocally supported Landsberg’s concept of sympathetic overactivity in most human obesity3,60–61,64.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [60]
Citations
Cites
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D’Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,288
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Chronic stress at work and the metabolic syndrome: prospective study
Chandola, T., Brunner, E., & Marmot, M. (2006) · BMJ · doi:10.1136/bmj.38693.435301.80 · Cited by 1,075
Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin
Pinto, S., Roseberry, A. G., Liu, H., Diano, S., Shanabrough, M., Cai, X., Friedman, J. M., & Horvath, T. L. (2004) · Science · doi:10.1126/science.1089459 · Cited by 987
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., & Eisenhofer, G. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.963 · Cited by 794
Self-citationDickinson, H. O., Mason, J. M., Nicolson, D. J., Campbell, F., Beyer, F. R., Cook, J. V., Williams, B., & Ford, G. A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000199800.72563.26 · Cited by 759
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614
Chiang, B. N., Perlman, L. V., & Epstein, F. H. (1969) · Circulation · doi:10.1161/01.cir.39.3.403 · Cited by 580
Rosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575
Sympathetic Neural Activation in Visceral Obesity
Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002) · Circulation · doi:10.1161/01.cir.0000041244.79165.25 · Cited by 557
Brunner, E. J., Hemingway, H., Walker, B. R., Page, M., Clarke, P., Juneja, M., Shipley, M. J., Kumari, M., Andrew, R., Seckl, J. R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000038364.26310.bd · Cited by 539
Sympathetic Activity in Obese Subjects With and Without Obstructive Sleep Apnea
Narkiewicz, K., van de Borne, P. J. H., Cooley, R. L., Dyken, M. E., & Somers, V. K. (1998) · Circulation · doi:10.1161/01.cir.98.8.772 · Cited by 525
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., & Tuck, M. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000091371.53502.d3 · Cited by 516
Self-citationEfficacy of low-dose spironolactone in subjects with resistant hypertension
Nishizaka, M. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)01032-x · Cited by 500
Fasting, Feeding and Regulation of the Sympathetic Nervous System
Landsberg, L., & Young, J. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197806082982306 · Cited by 492
Green, S. A., Cole, G., Jacinto, M. T., Innis, M. A., & Liggett, S. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49434-9 · Cited by 457
Regional Sympathetic Nervous Activity and Oxygen Consumption in Obese Normotensive Human Subjects
Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G., & Esler, M. (1997) · Circulation · doi:10.1161/01.cir.96.10.3423 · Cited by 404
Self-citationNeural mechanisms in human obesity-related hypertension
Rumantir, M. S., Vaz, M., Jennings, G. L., Collier, G., Kaye, D. M., Seals, D. R., Wiesner, G. H., Brunner-La Rocca, H. P., & Esler, M. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917080-00012 · Cited by 396
Self-citationEvidence for a Central Mechanism in Angiotensin Induced Hypertension.
Bickerton, R. K., & Buckley, J. P. (1961) · Experimental Biology and Medicine · doi:10.3181/00379727-106-26492 · Cited by 387
Leptin Gene Expression in the Brain and Pituitary Gland
Morash, B. A., Li, A., Murphy, P. R., Wilkinson, M., & Ur, E. (1999) · Endocrinology · doi:10.1210/endo.140.12.7288 · Cited by 384
LANDSBERG, L. (1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068066 · Cited by 373
Sympathetic and Cardiorenal Actions of Leptin
Haynes, W. G., Sivitz, W. I., Morgan, D. A., Walsh, S. A., & Mark, A. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.619 · Cited by 351
Baskin, D. G., Figlewicz, D. P., Woods, S. C., Porte, D., & Dorsa, D. M. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002003 · Cited by 344
Grassi, G. M., Dell’Oro, R., Facchini, A., Trevano, F. Q., Bolla, G. B., & Mancia, G. (2004) · Journal of Hypertension · doi:10.1097/00004872-200412000-00019 · Cited by 339
Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116542 · Cited by 321
Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., & Sharma, A. M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1699 · Cited by 320
Reflex sympathetic activation induces acute insulin resistance in the human forearm.
Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O., & Brant, D. O. (1993) · Hypertension · doi:10.1161/01.hyp.21.5.618 · Cited by 311
Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.
Nuutila, P., Koivisto, V. A., Knuuti, J. M., Ruotsalainen, U., Teräs, M., Haaparanta‐Solin, M., Bergman, J. R., Solin, O. H., Voipio-Pulkki, L. M., & Wegelius, U. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115780 · Cited by 309
Renal Denervation Attenuates the Sodium Retention and Hypertension Associated With Obesity
Kassab, S., Kato, T., Wilkins, F. C., Chen, R., Hall, J. E., & Granger, J. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.893 · Cited by 307
Heitmann, B. L., Eriksson, H., Ellsinger, B. M., Mikkelsen, K. L., & Larsson, B. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801082 · Cited by 298
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome
Grassi, G., Dell’Oro, R., Quarti-Trevano, F., Scopelliti, F., Seravalle, G., Paleari, F., Gamba, P. L., & Mancia, G. (2005) · Diabetologia · doi:10.1007/s00125-005-1798-z · Cited by 294
Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain.
Spraul, M., Ravussin, E., Fontvieille, A. M., Rising, R., Larson, D. E., & Anderson, E. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116760 · Cited by 293
Interactions Between Leptin and the Human Sympathetic Nervous System
Eikelis, N., Schlaich, M., Aggarwal, A., Kaye, D., & Esler, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000066289.17754.49 · Cited by 271
Self-citationGrassi, G., Colombo, M., Seravalle, G., Spaziani, D., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.64 · Cited by 256
Overweight and Hypertension: A 2-Way Street?
Julius, S., Valentini, M., & Palatini, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.807 · Cited by 253
Straznicky, N. E., Lambert, E. A., Lambert, G. W., Masuo, K., Esler, M. D., & Nestel, P. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0961 · Cited by 227
Self-citationGrassi, G., Seravalle, G., Dell'Oro, R., Trevano, F. Q., Bombelli, M., Scopelliti, F., Facchini, A., & Mancia, G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200309000-00027 · Cited by 225
Obstructive Sleep Apnea–Dependent and –Independent Adrenergic Activation in Obesity
Grassi, G. M., Facchini, A., Trevano, F. Q., Dell’Oro, R., Arenare, F., Tana, F., Bolla, G. B., Monzani, A., Robuschi, M., & Mancia, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000174243.39897.6c · Cited by 214
Huggett, R. J., Burns, J., Mackintosh, A. F., & Mary, D. A. S. G. (2004) · Hypertension · doi:10.1161/01.hyp.0000147893.08533.d8 · Cited by 211
Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
Hall, J. E. (1994) · Hypertension · doi:10.1161/01.hyp.23.3.381 · Cited by 204
Bray, G. A., York, D. A., & Fisler, J. S. (1989) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60393-3 · Cited by 203
Disparate cardiovascular effects of obesity and arterial hypertension
Messerli, F. H., Sundgaard-Riise, K., Reisin, E., Dreslinski, G. R., Dunn, F. G., & Frohlich, E. D. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91071-9 · Cited by 197
Masuo, K. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(96)00303-2 · Cited by 196
Self-citationLocation and regulation of rat angiotensinogen messenger RNA.
Cassis, L. A., Saye, J. A., & Peach, M. J. (1988) · Hypertension · doi:10.1161/01.hyp.11.6.591 · Cited by 192
喬, 嶋. (1992) · doi:10.11381/jjcdp1974.26.198 · Cited by 192
Brain regulation of food intake and appetite: molecules and networks
Roberger, C. B. (2005) · Cited by 191
Noradrenaline turnover during under- and over-eating in normal weight subjects
O’Dea, K., Esler, M., Leonard, P., Stockigt, J. R., & Nestel, P. J. (1982) · Metabolism · doi:10.1016/0026-0495(82)90178-0 · Cited by 189
Self-citationExercise training lowers resting renal but not cardiac sympathetic activity in humans.
Meredith, I. T., Friberg, P., Jennings, G. L., Dewar, E. M., Fazio, V. A., Lambert, G. W., & Esler, M. D. (1991) · Hypertension · doi:10.1161/01.hyp.18.5.575 · Cited by 189
Self-citationObesity-Induced Hypertension: New Concepts From the Emerging Biology of Obesity
Mark, A. L., Correia, M., Morgan, D. A., Shaffer, R. A., & Haynes, W. G. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.537 · Cited by 185
Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects
Wofford, M. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01293-6 · Cited by 184
Pathophysiology and Treatment of Obesity Hypertension
Wofford, M. R., & Hall, J. E. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382855 · Cited by 173
Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980.
Young, J. B., & Macdonald, I. A. (1992) · PubMed · Cited by 163
Regional Norepinephrine Turnover in Human Hypertension
Esler, M., Lambert, G., & Jennings, G. (1989) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968909045414 · Cited by 161
Self-citationReisin, E., Weir, M. R., Falkner, B., Hutchinson, H. G., Anzalone, D. A., & Hypertension, M. L. T. F. T. T. I. O. P. W. (1997) · Hypertension · doi:10.1161/01.hyp.30.1.140 · Cited by 158
Reduced Postprandial Skeletal Muscle Blood Flow Contributes to Glucose Intolerance in Human Obesity*
Baron, A., Laakso, M., Brechtel, G., Hoit, B. D., Watt, C., & Edelman, S. V. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1525 · Cited by 157
Sloper, J. J. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.097618 · Cited by 157
Weight Gain–Induced Blood Pressure Elevation
Masuo, K., Mikami, H., Ogihara, T., & Tuck, M. L. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1135 · Cited by 155
Self-citationThe Interconnection between Sympathetics, Microcirculation, and Insulin Resistance in Hypertension
Julius, S., Gudbrandsson, T., Jamerson, K., & Andersson, O. (1992) · Blood Pressure · doi:10.3109/08037059209065119 · Cited by 154
Effects of hypothalamic lesion on pancreatic autonomic nerve activity in the rat
Yoshimatsu, H., Niijima, A., Oomura, Y., Yamabe, K., & Katafuchi, T. (1984) · Brain Research · doi:10.1016/0006-8993(84)90222-1 · Cited by 152
Mills, P. J., Kennedy, B. P., Loredo, J. S., Dimsdale, J. E., & Ziegler, M. G. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00494.2005 · Cited by 146
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1998) · Endocrine Research · doi:10.3109/07435809809032689 · Cited by 143
Verhaar, M. C., Beutler, J. J., Gaillard, S., Koomans, H. A., Fijnheer, R., & Rabelink, T. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816010-00008 · Cited by 142
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?
Sharma, A. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000132568.71409.a2 · Cited by 136
Acute noradrenergic activation induces insulin resistance in human skeletal muscle
Lembo, G., Capaldo, B., Rendina, V., Iaccarino, G., Napoli, R., Guida, R., Trimarco, B., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e242 · Cited by 136
Sympathetics, insulin resistance and coronary risk in hypertension: the chicken-and-egg question
Julius, S., & Jamerson, K. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00001 · Cited by 127
Masuo, K., Katsuya, T., Fu, Y., Rakugi, H., Ogihara, T., & Tuck, M. L. (2005) · Circulation · doi:10.1161/circulationaha.104.519652 · Cited by 123
Self-citationChronic Management of Blood Pressure After Stroke
Pedelty, L., & Gorelick, P. B. (2004) · Hypertension · doi:10.1161/01.hyp.0000129170.50448.5f · Cited by 122
Subcutaneous obesity is not associated with sympathetic neural activation
Alvarez, G. E., Ballard, T. P., Beske, S. D., & Davy, K. P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01046.2003 · Cited by 121
Gender differences in muscle sympathetic nerve activity: effect of body fat distribution
Jones, P. P., Snitker, S., Skinner, J. S., & Ravussin, É. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e363 · Cited by 110
Pathogenesis of weight-related changes in blood pressure in dogs.
Rocchini, A. P., Moorehead, C., DeRemer, S. J., & Bondie, D. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.922 · Cited by 108
Angiotensinogen, angiotensin II and adipose tissue development
Ailhaud, G. P., Fukamizu, A., Massiéra, F., Négrel, R., Saint-Marc, P., & Teboul, M. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801501 · Cited by 102
Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
Haenni, A., & Lithell, H. (1999) · PubMed · Cited by 96
Reduced parasympathetic control of heart rate in obese dogs
Van Vliet, B. N., Hall, J. E., Mizelle, H. L., Montani, J. P., & Smith, M. J. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.2.h629 · Cited by 95
Forearm resistance vessel abnormalities and insulin resistance in obese adolescents.
Rocchini, A. P., Moorehead, C., Katch, V. L., Key, J., & Finta, K. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.615 · Cited by 86
Leptin in human plasma is derived in part from the brain, and cleared by the kidneys
Esler, M., Vaz, M. A. P., Collier, G. R., Nestel, P. J., Jennings, G., Kaye, D. M., Seals, D. R., & Lambert, G. W. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70289-0 · Cited by 80
Self-citationGuðbjörnsdóttir, S., Friberg, P., Elam, M., Attvall, S., Lönnroth, P., & Wallin, B. G. (1994) · Blood Pressure · doi:10.3109/08037059409102293 · Cited by 80
Abnormal Neurovascular Control during Sympathoexcitation in Obesity
Kuniyoshi, F. H. S., Trombetta, I. C., Batalha, L. T., Rondon, M. U. P. B., Laterza, M. C., Gowdak, M. M. G., Barretto, A. C. P., Halpern, A., Villares, S. M. F., Lima, E. G., et al. (2003) · Obesity Research · doi:10.1038/oby.2003.190 · Cited by 74
The Effects of Leptin Administration in Non‐obese Human Subjects
Mackintosh, R. M., & Hirsch, J. (2001) · Obesity Research · doi:10.1038/oby.2001.60 · Cited by 74
Seematter, G., Guenat, E., Schneiter, P., Cayeux, C., Jéquier, E., & Tappy, L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e799 · Cited by 74
Krum, H., Lambert, É., Windebank, E., Campbell, D. J., & Esler, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00885.2005 · Cited by 73
Self-citationPoehlman, É. T., Gardner, A. W., Goran, M. I., Arciero, P. J., Toth, M. J., Ades, P. A., & Calles-Escandón, J. (1995) · Journal of Applied Physiology · doi:10.1152/jappl.1995.78.3.802 · Cited by 70
Laaksonen, D. E., Laitinen, T. P., Schönberg, J., Rissanen, A., & NISKANEN, L. K. (2003) · Journal of Hypertension · doi:10.1097/00004872-200302000-00029 · Cited by 70
Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function
Eikelis, N., Lambert, G. W., Wiesner, G., Kaye, D. M., Schlaich, M. P., Morris, M. J., Hastings, J. A., Socratous, F., & Esler, M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00489.2003 · Cited by 68
Self-citationLeptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects
Narkiewicz, K., Kato, M., Phillips, B. G., Pesek, C. A., Choe, I., Winnicki, M., Palatini, P., Sivitz, W. I., & Somers, V. K. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106000-00014 · Cited by 68
Sympathetic neural control of the kidney in hypertension.
DiBona, G. F. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i28 · Cited by 64
The neurobiology of human obesity
Eikelis, N., & Esler, M. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2005.031385 · Cited by 61
Self-citationSharma, A. M., Wagner, T., & Marsalek, P. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001676 · Cited by 54
Muscle sympathetic nerve activity and hemodynamic alterations in middle-aged obese women
Ribeiro, M. M., Trombetta, I. C., Batalha, L. T., Rondon, M. U. P. B., Forjaz, C. L. M., Barretto, A. C. P., Villares, S. M., & Negrão, C. E. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000400006 · Cited by 54
Reduced brain leptin in patients with major depressive disorder and in suicide victims
Eikelis, N., Esler, M., Barton, D., Dawood, T., Wiesner, G., & Lambert, G. W. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001862 · Cited by 47
Self-citationRilmenidine normalizes fructose-induced insulin resistance and hypertension in rats.
Pénicaud, L., Berthault, M., Morin, J., Dubar, M., Ktorza, A., & Ferré, P. (1998) · PubMed · Cited by 44
Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients
Jordan, J., Engeli, S., Boschmann, M., Weidinger, G., Luft, F. C., Sharma, A. M., & Kreuzberg, U. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000188734.98463.82 · Cited by 41
Leptin as a Potential Treatment for Obesity: Progress to Date
Bell-Anderson, K. S., & Bryson, J. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403010-00002 · Cited by 36
Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity?
Esler, M., & Eikelis, N. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01294.2005 · Cited by 34
Self-citationElevation of sympathetic activity by eprosartan in young male subjects
Heusser, K. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00917-8 · Cited by 33
Moan, A., Høieggen, A., Nordby, G., Os, I., Eide, I. A., & Kjeldsen, S. E. (1995) · Metabolism · doi:10.1016/0026-0495(95)90034-9 · Cited by 32
Involvement of imidazoline-preferring receptors in regulation of sympathetic tone
Sannajust, F., & Head, G. A. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90036-1 · Cited by 28
Forearm haemodynamics in obese normotensive and hypertensive subjects
Raison, J., Safar, M. E., Cambien, F., & London, G. M. (1988) · Journal of Hypertension · doi:10.1097/00004872-198804000-00006 · Cited by 21
Effects of Free Fatty Acids on Insulin Sensitivity and Hemodynamics during Mental Stress1
Battilana, P., Seematter, G., Schneiter, P., Jéquier, E., & Tappy, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7096 · Cited by 16
The metabolic syndrome: cluster with a self-fulfilling loop?
Clemenz, M., Kintscher, U., & Unger, T. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202813.79964.4a · Cited by 8
Short-term (5-day) changes in food intake alter daily hemodynamics in rabbits
Antic, V. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03272-7 · Cited by 7
Esler, M. (2003) · Journal of Hypertension · doi:10.1097/00004872-200302000-00013 · Cited by 7
Self-citationThe renin-angiotensin system in obesity : metabolic and hemodynamic effects
Goossens, G. H. (2006) · doi:10.26481/dis.20060628gg · Cited by 1
Research works printed but not linked: 12
- 10.1161/circ.96.10.3423 · DOI
- 10.1161/hyp.25.4.893 · DOI
- 10.1161/hyp.31.1.64 · DOI
- 10.1161/hyp.25.4.560 · DOI
- Esler M. Looking at the sympathetic nervous system as a primary source. In: Zanchetti A Robertson JIS Birkenhager WH ed. Handbook of Hypertension: Hypertension Research in the Twentieth Century. Amsterdam the Netherlands: Elsevier; 2004; 81–103.
- Grassi G, Dell Oro R, Quarti-Trevano F, Scopelliti F, Seravalle G, Paleari F, Gamba PL, Mancia G. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005; 48: 1349–1356.
- 10.1161/circ.98.8.772 · DOI
- 10.1161/hyp.33.1.537 · DOI
- 10.1161/hyp.30.3.619 · DOI
- 10.1161/hyp.35.5.1135 · DOI
- Dickinson CJ. Neurogenic Hypertension. Oxford United Kingdom: Blackwell Scientific; 1965
- 10.1161/hyp.30.1.140 · DOI
Cited by
Sorted by citations
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 735
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616
Self-citationMahfoud, F., Schlaich, M. P., Kindermann, I., Ukena, C., Cremers, B., Brandt, M. C., Hoppe, U. C., Vonend, O., Rump, L. C., Sobotka, P. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.991869 · Cited by 577
Self-citationThe pathophysiology of hypertension in patients with obesity
DeMarco, V. G., Aroor, A. R., & Sowers, J. R. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.44 · Cited by 545
The human sympathetic nervous system: its relevance in hypertension and heart failure
Parati, G., & Esler, M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs041 · Cited by 538
Self-citation
Metadata
- Authors
- Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., & Lambert, E.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From the Human Neurotransmitter Laboratory, Baker Heart Research Institute, Melbourne, Australia.
- Venue
- Hypertension
- Published
- 2006-11
- Volume
- 48
- Issue
- 5
- Pages
- 787-796
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2119686163
- Cited by
- 443
- References
- 108
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 6 · 2023: 20 · 2022: 8 · 2021: 16 · 2020: 23 · 2019: 26 · 2018: 19 · 2017: 28 · 2016: 29 · 2015: 23 · 2014: 27 · 2013: 51 · 2012: 29
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- sympathetic activation, obesity, obesity-related hypertension, hypertension pathophysiology, sympathetic hyperactivity
- MeSH terms
- Animals, Disease Models, Animal, Humans, Hypertension, Hypothalamus, Obesity, Sympathetic Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review